This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Sathish Manda
Introduction
Sathish Manda is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of potential anticancer agents. His work is characterized by a strong focus on innovative compounds that may offer new therapeutic options for cancer treatment.
Latest Patents
Sathish Manda holds a patent for a compound titled "N-((1-phenyl-9H-pyrido[3,4-b]indol-3-yl)methyl)cinnamamides as potential anticancer agents and preparation thereof." This compound, represented by general formula A, is designed to be effective against human cancer cell lines. The general formula includes various substituents such as R=3-F, 3,4,5-OMe, 4-OMe, H, and others, showcasing a diverse range of chemical modifications aimed at enhancing its anticancer properties. He has 1 patent to his name.
Career Highlights
Sathish Manda is affiliated with the Council of Scientific and Industrial Research, where he engages in cutting-edge research and development. His work is instrumental in advancing the understanding of anticancer compounds and their potential applications in clinical settings.
Collaborations
Throughout his career, Sathish has collaborated with esteemed colleagues such as Ahmed Kamal and Nagesh Narayana. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their projects.
Conclusion
Sathish Manda's contributions to the field of medicinal chemistry, particularly in the development of anticancer agents, highlight his role as an innovative inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic applications in cancer treatment.